Deep-frozen shipping holds a payload around -40°C, colder than the standard -20°C frozen plateau and warmer than the -70°C ultra-low band. Like those other bands, it is a plateau rather than one exact line, usually run between -30°C and -45°C and still called -40°C the same way a -20°C freezer rarely sits at exactly -20°C. The band exists because some products degrade measurably faster at -20°C than a -40°C hold allows, but do not need the cost, the freezer type, or the handling burden that a -70°C ultra-low band demands.
It sits directly between -20°C frozen shipping and -70°C ultra-low shipping, and it inherits a problem from each side. It is cold enough that most standard freezers cannot reach it without modification, and warm enough that a coolant built for -70°C or colder runs far past what the product actually needs.
A plateau, not a line
Holding -40°C works the same way any other frozen plateau does: what matters is that the coldest and warmest points inside the payload space stay on the same side of the target, not that the whole box reads one exact number. A freezer built for this duty runs a compressor rated to hold -40°C continuously. A standard -20°C rated chest freezer pushed to its limit strains against a target it was never built for and eventually fails, often quietly, well before anyone notices the product has drifted.
Products that need this plateau
Certain biologics and cell-based products sit here because -20°C storage shortens their usable life more than a clinical timeline or a supply chain can absorb, while -70°C storage adds cost and freezer scarcity the product does not need to solve. Frozen plasma derivatives processed for an extended shelf life, some high-value seafood, and a narrow set of clinical trial materials with a defined but not indefinite frozen life all run at -40°C for the same reason: it is the coldest plateau that still buys the stability the product needs, and no colder.
Pharmaceutical manufacturers, biologics developers, blood and plasma processors, and specialty food distributors are the main users of this band, working alongside packaging engineers who size the coolant and quality teams who qualify the shipper against the same thermal test profiles any other frozen shipper is qualified against.
Coolant choices at -40°C
Dry ice, at around -78°C, is far colder than this plateau needs, and a packer who uses it anyway has to manage a headspace that can pull the payload well past -40°C if the coolant sits too close to the product. Most deep-frozen shippers instead run a phase change material formulated to melt near the -40°C mark, which holds the payload at its own melting point rather than at whatever a colder, unrelated coolant happens to settle at. Mechanically frozen coolant plates, blast-frozen in an industrial freezer before loading and cycled back through the same freezer once returned, are the other common choice, and the one most closed-loop shipping programmes use.
None of these options is a drop-in swap for another. A pack-out qualified around a -40°C phase change material cannot simply substitute frozen coolant plates without a fresh thermal test, because the two absorb heat on different curves even when they land on the same average reading. Packaging engineers pick one coolant path per programme and requalify the shipper any time the coolant, the quantity, or the plate source changes.
The equipment gap
Standard cold chain infrastructure was not built around this plateau. Hospitals, clinics and distribution hubs commonly stock a -20°C freezer for routine frozen product, and, where the product demands it, a -70°C ultra-low freezer for the coldest biologics. Very few sites stock a freezer built specifically to hold -40°C, because until a product needs it, there is little reason to add a third freezer type to a site already running two.
That gap forces a choice at the receiving end that has nothing to do with how well the shipment travelled. A site with only -20°C and -70°C freezers either stores a -40°C product too warm, shortening its usable life, or too cold, adding cost and freezer space nobody planned for. Manufacturers shipping into this plateau increasingly confirm the exact freezer available at each receiving site before the first shipment moves, because discovering the gap after product has already arrived is a distribution failure, not a packaging one.
Some sites work around the gap by running a -70°C freezer a few degrees warm, holding it deliberately at -40°C for a specific product line, though that trades away the freezer's ability to also serve anything genuinely needing -70°C at the same time. Others simply route deep-frozen product through a courier network with dry ice replenishment built in, treating the shipper itself as the cold storage until a purpose-built freezer is justified by enough volume.
Choosing -20°C or -70°C instead
Deep-frozen is not the right answer just because a product is described as sensitive. A biologic that holds full stability at -20°C for as long as the supply chain needs gains nothing from the extra cost and freezer complexity of -40°C. A product that genuinely needs -70°C stability loses potency faster at -40°C than the plateau's convenience is worth. The band earns its place only where the stability data specifically supports it over both neighboring plateaus, not as a compromise picked to avoid choosing one side.